FDA NDC Directory · JSON-LD · Markdown

PYQUVI

NDC 73289-0089 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namedeflazacort
Labeler / ManufacturerAucta Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA219417
Dosage form / routeSUSPENSION · ORAL
Active ingredientsDEFLAZACORT (22.75 mg/mL)
Marketing started20250630
Package count1

External sources

Source: openFDA. Public-domain (CC0).